Acquiring Company
ARCHIMED
Acquired Company
ZimVie
Palm Beach GardensFinancial ServicesHealth CareVenture CapitalMedicalventure capital & private equityManufacturingBiotechnologyHealth CareDescription
ZimVie has officially concluded its public trading following the acquisition by ARCHIMED for $19 per share. The deal, valued at approximately $730 million, gained shareholder approval on October 10, 2025, and was finalized shortly thereafter. ZimVie now operates as a wholly-owned subsidiary of ARCHIMED, focusing on its dental implants division.
Quick answer
ARCHIMED is acquiring ZimVie, announced November 6, 2025.
- How much did ARCHIMED pay for ZimVie?
- The deal value was not disclosed.
- What does ARCHIMED do?
- ARCHIMED is a private equity firm focusing on the healthcare sector.
- Where are ARCHIMED and ZimVie based?
- ZimVie is based in Palm Beach Gardens, Florida, United States.
- Who are the decision-makers at ARCHIMED?
- Fundz holds 1 contact at ARCHIMED. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Venture Capital
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ARCHIMED completes acquisition of ZimVie Inc. (October 20, 2025)
- Perceptive Capital to merge with Freenome Holdings (December 5, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- GTCR secures court approval to acquire Surmodics (November 11, 2025)
- Galecto, Inc. Acquires Damora Therapeutics, Inc. (November 10, 2025)
- OSR Holdings to acquire Woori IO for diabetes care (October 14, 2025)
Who to call at ARCHIMED, and when
When ARCHIMED changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARCHIMED raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARCHIMED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARCHIMED. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARCHIMED makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ZimVie?
ZimVie was acquired by ARCHIMED. The deal was reported on November 6, 2025. ARCHIMED is a private equity firm focusing on the healthcare sector. It invests in and supports companies that provide innovative solutions in medical technology and services. ARCHIMED is privately held and operates in Financial Services.
When did ARCHIMED acquire ZimVie?
ARCHIMED's acquisition of ZimVie was reported on November 6, 2025. ZimVie has officially concluded its public trading following the acquisition by ARCHIMED for $19 per share. The deal, valued at approximately $730 million, gained shareholder approval on October 10, 2025, and was finalized shortly thereafter. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ZimVie do?
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It is privately held, operating in Manufacturing, and is based in Palm Beach Gardens.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.